Development of computational pregnant female and fetus models and assessment of radiation dose from positron-emitting tracers
Authors:
- 28 June 2016
- journal article
- research article
- Published by Springer Nature in European Journal of Nuclear Medicine and Molecular Imaging
- Vol. 43 (13) , 2290-2300
Abstract
Purpose Molecular imaging using PET and hybrid (PET/CT and PET/MR) modalities nowadays plays a pivotal role in the clinical setting for diagnosis and staging, treatment response monitoring, and radiation therapy treatment planning of a wide range of oncologic malignancies. The developing embryo/fetus presents a high sensitivity to ionizing radiation. Therefore, estimation of the radiation dose delivered to the embryo/fetus and pregnant patients from PET examinations to assess potential radiation risks is highly praised. Methods We constructed eight embryo/fetus models at various gestation periods with 25 identified tissues according to reference data recommended by the ICRP publication 89 representing the anatomy of the developing embryo/fetus. The developed embryo/fetus models were integrated into realistic anthropomorphic computational phantoms of the pregnant female and used for estimating, using Monte Carlo calculations, S-values of common positron-emitting radionuclides, organ absorbed dose, and effective dose of a number of positron-emitting labeled radiotracers. Results The absorbed dose is nonuniformly distributed in the fetus. The absorbed dose of the kidney and liver of the 8-week-old fetus are about 47.45 % and 44.76 % higher than the average absorbed dose of the fetal total body for all investigated radiotracers. For 18F-FDG, the fetal effective doses are 2.90E-02, 3.09E-02, 1.79E-02, 1.59E-02, 1.47E-02, 1.40E-02, 1.37E-02, and 1.27E-02 mSv/MBq at the 8th, 10th, 15th, 20th, 25th, 30th, 35th, and 38th weeks of gestation, respectively. Conclusion The developed pregnant female/fetus models matching the ICRP reference data can be exploited by dedicated software packages for internal and external dose calculations. The generated S-values will be useful to produce new standardized dose estimates to pregnant patients and embryo/fetus from a variety of positron-emitting labeled radiotracers.Keywords
Funding Information
- Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (CH) (31003A-149957)
This publication has 30 references indexed in Scilit:
- 18F-FDG PET in Pregnancy and Fetal Radiation Dose EstimatesJournal of Nuclear Medicine, 2011
- Absorbed 18F-FDG Dose to the Fetus During Early Pregnancy: FIGURE 1.Journal of Nuclear Medicine, 2010
- IN VIVO QUANTIFICATION OF 18F-FDG UPTAKE IN HUMAN PLACENTA DURING EARLY PREGNANCYHealth Physics, 2009
- MIRD Pamphlet No. 21: A Generalized Schema for Radiopharmaceutical Dosimetry—Standardization of NomenclatureJournal of Nuclear Medicine, 2009
- AbstractAnnals of the ICRP, 2008
- Main TextAnnals of the ICRP, 2008
- A boundary-representation method for designing whole-body radiation dosimetry models: pregnant females at the ends of three gestational periods—RPI-P3, -P6 and -P9Physics in Medicine & Biology, 2007
- Molecular imaging of cancer with positron emission tomographyNature Reviews Cancer, 2002
- The GSF family of voxel phantomsPhysics in Medicine & Biology, 2001
- Fetal Thyroid Dose from Intakes of Radioiodine by the MotherHealth Physics, 1982